Our data reveal a mechanism by which METTL3 negatively regulates hepatic Cd36 and Ccl2 gene transcription via a histone modification pathway for protection against NASH progression. This evidence concerns the gene METTL3 and metabolic dysfunction-associated steatohepatitis.